Finalist
LiverSync®
with support from earthware
Summary of work
Chronic liver disease patients are at risk of developing hepatic encephalopathy (HE), a potentially fatal complication of liver cirrhosis. HE often goes undetected and untreated but monitoring cognitive performance can provide an early warning that patients are at risk.
Norgine previously developed paper and digital cognitive tests as a diagnostic tool. Clinical evaluation established these tests as “gold standard”. However, no solution supported automation of regular testing, analysis or real time sharing of data with HCPs.
LiverSync® is the first app/medical device of its kind for patients at risk of developing HE. The bespoke algorithm analyses patient’s cognitive test performance to identify concerning trends and triggers notifications to patients and their carers to seek help, whilst prompting HCPs to call the patient in for review.
The HCP’s real-time view is enabled via a custom API that facilitates secure transfer of encrypted data from the patient’s app. Patients remain in control of this connection, authorizing HCP access in the first instance, with the ability to revoke access at any time.
LiverSync®’s continuous monitoring facilitates earlier intervention, empowering patients to manage their own condition, minimising hospitalisation, reducing the burden on carers, and enhancing HCP’s ability to prioritise patients based on individual needs.
Judges’ comments
This entry from Norgine and earthware impressed the judges with its patient co-creation and quantified objectives. It was very bold and innovative, adapting as it progressed. It had a big, multi-country reach and the technology usage was very good. Overall good insights a fantastic campaign, and the judges look forward to seeing it progress.
